Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR (2023) Thyroid cancer. Lancet (London, England) 401(10387):1531–1544

Article  PubMed  Google Scholar 

Uppal N, Cunningham Nee Lubitz C, James B (2022) The cost and financial burden of thyroid cancer on patients in the us: a review and directions for future research. JAMA Otolaryngol Head Neck Surg 148(6):568–575

Article  PubMed  Google Scholar 

Fagin JA, Wells SA Jr (2016) Biologic and clinical perspectives on thyroid cancer. N Engl J Med 375(23):2307

PubMed  Google Scholar 

Parameswaran R, Shulin HuJ, Min En N, Tan WB, Yuan NK (2017) Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation. Ann R Coll Surg Engl 99(2):151–154

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ito Y, Hirokawa M, Masuoka H, Yabuta T, Fukushima M, Kihara M, Higashiyama T, Takamura Y, Kobayashi K, Miya A et al (2013) Distant metastasis at diagnosis and large tumor size are significant prognostic factors of widely invasive follicular thyroid carcinoma. Endocr J 60(6):829–833

Article  PubMed  Google Scholar 

Grimm D (2022) Recent advances in thyroid cancer research. Int J Mol Sci 23(9):4631

Article  PubMed  PubMed Central  Google Scholar 

Nabhan F, Dedhia PH, Ringel MD (2021) Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer 149(5):984–992

Article  CAS  PubMed  Google Scholar 

Laha D, Nilubol N, Boufraqech M (2020) New therapies for advanced thyroid cancer. Front Endocrinol 11:82

Article  Google Scholar 

Hong K, Cen K, Chen Q, Dai Y, Mai Y, Guo Y (2023) Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Front Immunol 14:1128390

Article  CAS  PubMed  PubMed Central  Google Scholar 

Razaghi A, Poorebrahim M, Sarhan D, Björnstedt M (2021) Selenium stimulates the antitumour immunity: insights to future research. Eur J Cancer (Oxford, England: 1990) 155:256–267

Article  CAS  Google Scholar 

Zhang F, Li X, Wei Y (2023) Selenium and selenoproteins in health. Biomolecules 13(5):799

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drutel A, Archambeaud F, Caron P (2013) Selenium and the thyroid gland: more good news for clinicians. Clin Endocrinol 78(2):155–164

Article  CAS  Google Scholar 

Rua RM, Nogales F, Carreras O, Ojeda ML (2023) Selenium, selenoproteins and cancer of the thyroid. J Trace Elem Med Biol Organ Soc Miner Trace Elem (GMS) 76:127115

Article  CAS  Google Scholar 

Wichman J, Winther KH, Bonnema SJ, Hegedüs L (2016) Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyr Off J Am Thyr Assoc 26(12):1681–1692

Article  CAS  Google Scholar 

Li T, Yang W, Li M, Byun DS, Tong C, Nasser S, Zhuang M, Arango D, Mariadason JM, Augenlicht LH (2008) Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res 52(11):1289–1299

Article  CAS  PubMed  Google Scholar 

Elhodaky M, Diamond AM (2018) Selenium-binding protein 1 in human health and disease. Int J Mol Sci 19(11):3437

Article  PubMed  PubMed Central  Google Scholar 

Ma J, Huang X, Xu J, Li Z, Lai J, Shen Y, Zhao J, Sun X, Ma L (2023) SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway. Mol Med (Cambridge, Mass) 29(1):121

Article  CAS  Google Scholar 

Stadhouders R, Filion GJ, Graf T (2019) Transcription factors and 3D genome conformation in cell-fate decisions. Nature 569(7756):345–354

Article  CAS  PubMed  Google Scholar 

Song L, Luo ZQ (2019) Post-translational regulation of ubiquitin signaling. J Cell Biol 218(6):1776–1786

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dagar G, Kumar R, Yadav KK, Singh M, Pandita TK (2023) Ubiquitination and deubiquitination: implications on cancer therapy. Biochim Biophys Acta 1866(4):194979

Article  CAS  Google Scholar 

Li YC, Cai SW, Shu YB, Chen MW, Shi Z (2022) USP15 in cancer and other diseases: from diverse functionsto therapeutic targets. Biomedicines 10(2):474

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun X, Tang H, Chen Y, Chen Z, Hu Z, Cui Z, Tao Y, Yuan J, Fu Y, Zhuang Z et al (2023) Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer. Nature cancer 4(5):716–733

Article  CAS  PubMed  Google Scholar 

Chen LL, Smith MD, Lv L, Nakagawa T, Li Z, Sun SC, Brown NG, Xiong Y, Xu YP (2020) USP15 suppresses tumor immunity via deubiquitylation and inactivation of TET2. Sci Adv. https://doi.org/10.1126/sciadv.abc9730

Article  PubMed Central  Google Scholar 

Jeong JY, Wang Y, Sytkowski AJ (2009) Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner. Biochem Biophys Res Commun 379(2):583–588

Article  CAS  PubMed  Google Scholar 

Jeong JY, Zhou JR, Gao C, Feldman L, Sytkowski AJ (2014) Human selenium binding protein-1 (hSP56) is a negative regulator of HIF-1α and suppresses the malignant characteristics of prostate cancer cells. BMB Rep 47(7):411–416

Article  PubMed  PubMed Central  Google Scholar 

de Jong RN, Ab E, Diercks T, Truffault V, Daniëls M, Kaptein R, Folkers GE (2006) Solution structure of the human ubiquitin-specific protease 15 DUSP domain. J Biol Chem 281(8):5026–5031

Article  Google Scholar 

Marciel MP, Hoffmann PR (2019) Molecular mechanisms by which selenoprotein K regulates immunity and cancer. Biol Trace Elem Res 192(1):60–68

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu C, Wang S, Du Y, Dai Y, Huai Q, Li X, Du Y, Dai H, Yuan W, Yin S et al (2022) Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer. BMC Gastroenterol 22(1):437

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng H, Zhao X, Tang C (2021) Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling. Cancer Chemother Pharmacol 88(2):223–233

Article  CAS  PubMed  Google Scholar 

Zhang X, Hong R, Bei L, Hu Z, Yang X, Song T, Chen L, Meng H, Niu G, Ke C (2022) SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial-mesenchymal transition. Open medicine (Warsaw, Poland) 17(1):1390–1404

Article  CAS  PubMed  Google Scholar 

Huang KC, Park DC, Ng SK, Lee JY, Ni X, Ng WC, Bandera CA, Welch WR, Berkowitz RS, Mok SC et al (2006) Selenium binding protein 1 in ovarian cancer. Int J Cancer 118(10):2433–2440

Article  CAS  PubMed  Google Scholar 

Han S, Wang R, Zhang Y, Li X, Gan Y, Gao F, Rong P, Wang W, Li W (2022) The role of ubiquitination and deubiquitination in tumor invasion and metastasis. Int J Biol Sci 18(6):2292–2303

Article  CAS